Advertisement
Skip to Content
Morningstar

T. Rowe Price Health Sciences PRHSX

Morningstar Analyst Rating
Analyst rating as of
  • NAV / 1-Day Return 90.39  /  0.38 %
  • Total Assets 16.2 Bil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 34%

USD | NAV as of Jan 26, 2023 | 1-Day Return as of Jan 26, 2023, 11:14 PM GMT+00:00

Morningstar’s Analysis PRHSX

Will PRHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Process Pillar

The Process Pillar is our assessment of how sensible, clearly defined, and repeatable PRHSX’s performance objective and investment process is for both security selection and portfolio construction.

People Pillar

The People Pillar is our evaluation of the PRHSX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

Parent Pillar

The Parent Pillar is our rating of PRHSX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Offers an edge in the healthcare sector.

Senior Analyst

Summary

| by Adam Sabban

T. Rowe Price Health Sciences has the expertise and structure it needs to add value in this rapidly evolving market segment, resulting in a Morningstar Analyst Rating of Silver.

Unlock our full analysis with Morningstar Investor